SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009792
Filing Date
2022-05-13
Accepted
2022-05-13 07:30:45
Documents
92
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20220331.htm   iXBRL 10-Q 3085117
2 EX-31.1 itrm-ex31_1.htm EX-31.1 21102
3 EX-31.2 itrm-ex31_2.htm EX-31.2 21456
4 EX-32.1 itrm-ex32_1.htm EX-32.1 12740
5 EX-32.2 itrm-ex32_2.htm EX-32.2 12732
  Complete submission text file 0000950170-22-009792.txt   12872691

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20220331_pre.xml EX-101.PRE 502905
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20220331.xsd EX-101.SCH 83908
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itrm-20220331_def.xml EX-101.DEF 348797
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20220331_lab.xml EX-101.LAB 599429
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itrm-20220331_cal.xml EX-101.CAL 57296
86 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20220331_htm.xml XML 2743575
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 22920244
SIC: 2834 Pharmaceutical Preparations